Optimal omegas - barriers and novel methods to narrow omega-3 gaps. A narrative review
- PMID: 38371504
- PMCID: PMC10869628
- DOI: 10.3389/fnut.2024.1325099
Optimal omegas - barriers and novel methods to narrow omega-3 gaps. A narrative review
Abstract
Dietary intakes of omega-3 long chain polyunsaturated fatty acids (O3LC-PUFAs) such as eicosapentaenoic and docosahexaenoic acid are central to development and health across the life course. O3LC-PUFAs have been linked to neurological development, maternal and child health and the etiology of certain non-communicable diseases including age-related cognitive decline, cardiovascular disease, and diabetes. However, dietary inadequacies exist in the United Kingdom and on a wider global scale. One predominant dietary source of O3LC-PUFAs is fish and fish oils. However, growing concerns about overfishing, oceanic contaminants such as dioxins and microplastics and the trend towards plant-based diets appear to be acting as cumulative barriers to O3LC-PUFAs from these food sources. Microalgae are an alternative provider of O3LC-PUFA-rich oils. The delivery of these into food systems is gaining interest. The present narrative review aims to discuss the present barriers to obtaining suitable levels of O3LC-PUFAs for health and wellbeing. It then discusses potential ways forward focusing on innovative delivery methods to utilize O3LC-PUFA-rich oils including the use of fortification strategies, bioengineered plants, microencapsulation, and microalgae.
Keywords: bioavailability; delivery methods; docosahexaenoic acid; eicosapentaenoic acid; food fortification; long-chain polyunsaturated fatty acids; microalgae; microencapsulation.
Copyright © 2024 Derbyshire, Birch, Bonwick, English, Metcalfe and Li.
Conflict of interest statement
ED was employed by Nutritional Insight Limited. CB and GB were employed by AgriFood X Limited. AE was employed by HTC Group Limited. PM was employed by Efficiency Technologies Limited. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Fortification of foods with omega-3 polyunsaturated fatty acids.Crit Rev Food Sci Nutr. 2014;54(1):98-114. doi: 10.1080/10408398.2011.578221. Crit Rev Food Sci Nutr. 2014. PMID: 24188235 Review.
-
Australian food sources and intakes of omega-6 and omega-3 polyunsaturated fatty acids.Ann Nutr Metab. 1999;43(6):346-55. doi: 10.1159/000012803. Ann Nutr Metab. 1999. PMID: 10725768
-
Dried blood spot omega-3 and omega-6 long chain polyunsaturated fatty acid levels in 7-9 year old Zimbabwean children: a cross sectional study.BMC Clin Pathol. 2016 Aug 5;16:14. doi: 10.1186/s12907-016-0035-7. eCollection 2016. BMC Clin Pathol. 2016. PMID: 27499701 Free PMC article.
-
Metabolic Engineering Strategies for the Enhanced Microalgal Production of Long-Chain Polyunsaturated Fatty Acids (LC-PUFAs).Biotechnol J. 2019 Jun;14(6):e1900043. doi: 10.1002/biot.201900043. Epub 2019 May 27. Biotechnol J. 2019. PMID: 31045311 Review.
-
Encapsulation and Protection of Omega-3-Rich Fish Oils Using Food-Grade Delivery Systems.Foods. 2021 Jul 6;10(7):1566. doi: 10.3390/foods10071566. Foods. 2021. PMID: 34359436 Free PMC article. Review.
Cited by
-
Vitamin D and LC-PUFA and the Presence of Fetal Heart Defects-A Further Part of a Case-Control Study.Nutrients. 2024 Dec 24;17(1):18. doi: 10.3390/nu17010018. Nutrients. 2024. PMID: 39796451 Free PMC article.
-
Effects of Salinity on the Growth Performance and Docosahexaenoic Acid Positional Distribution in Triacylglycerols of the Newly Isolated Schizochytrium sp. FJ-1.Mar Drugs. 2025 Jun 23;23(7):260. doi: 10.3390/md23070260. Mar Drugs. 2025. PMID: 40710485 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources